PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 2026Independent Nurse0 citations

Prescribing SGLT2 inhibitors: problems and solutions

View Full Paper
DMDavid Morris

Key Points

  • This review aims to address the challenges associated with prescribing SGLT2 inhibitors for diabetes treatment.
  • Review of existing literature on SGLT2 inhibitors
  • Assessment of potential side effects
  • Discussion of management strategies for adverse effects.
  • SGLT2 inhibitors have expanded in diabetes treatment but present significant side effects.
  • Management strategies can alleviate issues related to adverse effects.
  • Review highlights the importance of monitoring and patient education.

Abstract

Use of SGLT2 inhibitors to treat diabetes has expanded greatly over recent years. Here David Morris looks at their possible side effects and how these might be managed

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

David Morris (2026) studied this question.

synapsesocial.com/papers/6a095bdd7880e6d24efe1b36https://doi.org/10.12968/indn.2026.4.12
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Risk of Phimosis Associated With SGLT2i Versus GLP-1RA: A Danish Cohort Study2025 · 3 citations
  2. 2Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes2017 · 7,881 citations
  3. 3Diabetic ketoacidosis in a patient with type 2 diabetes induced by multiple triggers: a case report and implications for clinical practice2024 · 2 citations
  4. 4Fournier Gangrene Associated With Sodium–Glucose Cotransporter-2 Inhibitors2019 · 231 citations
  5. 5Urinary tract and genital infections in patients with type 2 diabetes treated with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis of randomized controlled trials2016 · 254 citations